Literature DB >> 9692682

Evaluation of residual cellularity and proliferation on preoperatively treated breast cancer: a comparison between image analysis and light microscopy analysis.

V Corletto1, P Verderio, R Giardini, S Cipriani, S Di Palma, F Rilke.   

Abstract

Histopathology has been suggested as a reliable method for tumour reduction evaluation of preoperatively treated breast cancer. Immunocytochemistry can be used to enhance the visibility of residual tumour cellularity and in the evaluation of its proliferative activity. We compared Image Analysis (IA) with Light Microscopy Analysis (LMA) on sections of breast carcinomas treated with preoperative chemo- or chemo/radiotherapy in the evaluation of the Neoplastic Cell Density (NCD) (69 cases) and the Proliferation Index (PI) (35 cases). NCD was expressed as the immunoreactive area to cytokeratin over the total original neoplastic area and PI was expressed as the number of immunostained tumoural nuclei with MIB 1 MoAb over the total of tumoural nuclei. The intraobserver agreement and that between IA and LMA for both indices were estimated by the common (kappa(w)) and the jackknife weighted kappa statistic (kappa(w)). The extent of agreement of each considered category was also assessed by means of the category-specific kappa statistics (kappa(cs)). The intraobserver agreement within LMA for NCD and PI and that between IA and LMA for PI were both satisfactory. Upon evaluation of the NCD, the agreement between IA and LMA showed unsatisfactory results, especially when the ratio between the residual tumour cells and the background was critical.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692682      PMCID: PMC4611108          DOI: 10.1155/1998/630295

Source DB:  PubMed          Journal:  Anal Cell Pathol        ISSN: 0921-8912            Impact factor:   2.916


  3 in total

1.  Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.

Authors:  Sibylle Gündisch; Julia Slotta-Huspenina; Paolo Verderio; Chiara Maura Ciniselli; Sara Pizzamiglio; Christina Schott; Enken Drecoll; Christian Viertler; Kurt Zatloukal; Marcel Kap; Peter Riegman; Irene Esposito; Katja Specht; Gregor Babaryka; Martin Asslaber; Koppany Bodó; Michael den Bakker; Jan den Hollander; Falko Fend; Jens Neumann; Simone Reu; Aurel Perren; Rupert Langer; Alessandro Lugli; Ingrid Becker; Thomas Richter; Gian Kayser; Annette M May; Fatima Carneiro; José Manuel Lopes; Leslie Sobin; Heinz Höfler; Karl-Friedrich Becker
Journal:  Virchows Arch       Date:  2014-08-02       Impact factor: 4.064

2.  Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.

Authors:  Juho Konsti; Mikael Lundin; Heikki Joensuu; Tiina Lehtimäki; Harri Sihto; Kaija Holli; Taina Turpeenniemi-Hujanen; Vesa Kataja; Liisa Sailas; Jorma Isola; Johan Lundin
Journal:  BMC Clin Pathol       Date:  2011-01-25

3.  External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.

Authors:  Irene Terrenato; Vincenzo Arena; Sara Pizzamiglio; Ilaria Pennacchia; Letizia Perracchio; Simonetta Buglioni; Cristiana Ercolani; Francesca Sperati; Leopoldo Costarelli; Elena Bonanno; Daniela Baldini; Silvia Candia; Anna Crescenzi; Antonella Dal Mas; Claudio Di Cristofano; Vito Gomes; Lucia Rosalba Grillo; Paola Pasquini; Maria Nicoletta Pericoli; Maria Teresa Ramieri; Domenica Di Stefano; Luigi Ruco; Stefania Scarpino; Domenico Vitolo; Giulia d'Amati; Angelo Paradiso; Paolo Verderio; Marcella Mottolese
Journal:  J Exp Clin Cancer Res       Date:  2013-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.